MicroTech Medical Hangzhou Co Ltd
HKEX:2235

Watchlist Manager
MicroTech Medical Hangzhou Co Ltd Logo
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Watchlist
Price: 4.55 HKD 1.11% Market Closed
Market Cap: 1.9B HKD
Have any thoughts about
MicroTech Medical Hangzhou Co Ltd?
Write Note

MicroTech Medical Hangzhou Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MicroTech Medical Hangzhou Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Cash & Cash Equivalents
ÂĄ1.9B
CAGR 3-Years
152%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash & Cash Equivalents
ÂĄ1.3B
CAGR 3-Years
120%
CAGR 5-Years
70%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash & Cash Equivalents
ÂĄ6.5B
CAGR 3-Years
35%
CAGR 5-Years
57%
CAGR 10-Years
36%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash & Cash Equivalents
ÂĄ20.5B
CAGR 3-Years
17%
CAGR 5-Years
9%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash & Cash Equivalents
ÂĄ1.7B
CAGR 3-Years
11%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash & Cash Equivalents
ÂĄ7.5B
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MicroTech Medical Hangzhou Co Ltd
Glance View

Market Cap
1.9B HKD
Industry
Health Care

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research, development, manufacture, and sale of diabetes management medical devices. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-10-19. The firm's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The firm's products, such as artificial pancreas, are in the process of research and development. The firm's products are sold to overseas markets such as the United States and the European Union.

Intrinsic Value
5.84 HKD
Undervaluation 22%
Intrinsic Value
Price

See Also

What is MicroTech Medical Hangzhou Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.9B CNY

Based on the financial report for Dec 31, 2023, MicroTech Medical Hangzhou Co Ltd's Cash & Cash Equivalents amounts to 1.9B CNY.

What is MicroTech Medical Hangzhou Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
152%

Over the last year, the Cash & Cash Equivalents growth was -8%. The average annual Cash & Cash Equivalents growth rates for MicroTech Medical Hangzhou Co Ltd have been 152% over the past three years .

Back to Top